For Cipla, Affordability Is Key: YK Hamied
  • Elizabeth George
  • Feb 04 2014

January 29: Cipla Chairman Y.K. Hamied tells Mini Menon about the company’s transformation from a low-cost manufacturer to spearheading pharma innovation across geographies. He discusses how Cipla seeks to replicate the success of the affordable Triomune HIV drug in other areas, while describing the Cipla’s new business model and strategy as the Indian pharma sector changes.